How long is the lead time for production?

The average lead time is within 15 workdays, regardless of peak or off-peak seasons.

What quality certifications does the company hold?

The company has passed ISO9001:2015 and ISO13485 certifications.

Is there a quality inspection process for finished products?

Yes, 100% inspection including visual and functional checks is performed on all finished products.

56 Series Hematology Analyzer

Name: LC2 Lyse Lyser-2 Suitable for Dymind Df50/51/52/53/55/56 Series Hematology Analyzer
Brand: Zhejiang Xinke Medical Technology Co., Ltd.
SKU: 2162122805

Zhejiang, ChinaZhejiang Xinke Medical Technology Co., Ltd.

US$1.00

1 Piece

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Reagent

Transport Package

Carton

Model NO.

JXK-351

Specification

500ml

Trademark

xinke

Origin

China

HS Code

3822190090

Production Capacity

500000/Ctns

Key features

Compatible with Dymind Series: Specifically designed for Dymind Df50/51/52/53/55/56 Hematology Analyzers.

ISO 13485 Certified: Manufactured under ISO9001 and ISO13485 quality management systems.

Flexible Customization: Offers flexible customization options for reagent specifications.

OEM Service Available: Full OEM service provided for various analyzer brands.

100% Quality Inspection: Every finished product undergoes visual and functional inspection.

Fast Lead Time: Peak and off-peak season lead time within 15 working days.

Established Manufacturer: Founded in 2004 with 20 years of export experience.

Wide Payment Options: Accepts LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

Company profile

Importers and ExportersYears of Export Experience

Zhejiang Xinke Medical Technology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: OEM Service Available CertifiedCustomization Options: Flexible customization CertifiedExport Year: 20 Years CertifiedNearest Port: Ningbo PortAverage Response Time: ≤2.78h

AI-Powered supplier vetting

SummaryThe supplier operates in the clinical in vitro diagnostic reagent field and reports ten years of ISO9001 and ISO13485 quality-system certification. It offers flexible customization, has OEM experience with well-known brands, possesses self-managed import/export rights, and has exported for 20 years, with exports representing 51%–70% of total sales. Quality inspection procedures are documented and consistently followed, while stated lead times are within 15 working days in both peak and off-season. However, the supplier reports no inventory, overseas warehouse, overseas showroom, overseas agents or branches, offline trade-show participation, ODM service, SDK, recent new-product development, ERP, OA, CRM, SAP, or broader digitalization initiatives. Financial information is inconsistent or insufficiently interpretable in the provided records, so financial credibility cannot be determined.

Supplier typeThe supplier identifies itself as a company in the clinical in vitro diagnostic reagent field and has self-managed import/export rights with 20 years of export experience. This supports classification as an export-capable manufacturer or supplier in the medical in vitro diagnostics sector.

CertificationsThe company states that it has maintained ISO9001 and ISO13485 quality-system certifications for ten years. These explicitly documented certifications support a positive assessment of its quality-system credentials.

R&D capabilityThe supplier reports no new products in the past year, no ODM service, no available SDK, and no current enterprise digitalization or technical-transformation plan. These explicit limitations indicate weak demonstrated innovation capability.

Customization capabilityThe supplier explicitly provides flexible customization through both its R&D and design-service capabilities. This directly supports a positive assessment of customization capability, although ODM service is not offered.

Client casesThe supplier states that it provides OEM services for well-known brands, which is evidence of relevant customer experience. No specific brand names, project details, or verifiable case descriptions are provided, so the evidence is positive but limited.